Modified ARCA analogs providing enhanced translational properties of capped mRNAs. Issue 13 (3rd July 2018)

• Record Type: Journal Article
• Authors: Kocmik, Ilona; Piecyk, Karolina; Rudzinska, Magdalena; Niedzwiecka, Anna; Darzynkiewicz, Edward; Grzela, Renata; Jankowska-Anyszka, Marzena
• Is Part Of: Cell cycle. Volume 17:Issue 13(2018)
• Page Start: 1624
• Page End: 1636
• Publication Date: 2018-07-03
• Subjects: Cap -- ARCA cap -- N2 guanosine modification -- cap-dependent translation -- RNA therapy; Cell cycle -- Periodicals; 571.84377
• DOI: 10.1080/15384101.2018.1486164
• Languages: English
• ISSNs: 1538-4101

Abstract

ABSTRACT: Nowadays gene manipulation techniques ("DNA therapy") undergo progressive development and become widely used in industry and medicine. Since new advances in mRNA technologies are capable for obtaining particles with increased stability and translational efficiency, RNA become an attractive alternative for advancement of DNA therapy. For the past years studies have been conducted to explore different modification in mRNA cap structure and its effect on RNA properties. Recently we have shown that modification of the cap structure at the N2 position of 7-methylguanosine leads to an enhancement in translation inhibition. Currently, we have decided to exploit translational properties of mRNA capped with the ARCA (anti-reversed cap) analogs modified within N2 position of purine moiety s. We designed and synthesized three new dinucleotide cap analogs and investigated them in the rabbit reticulocyte lysate (RRL) and the human embryonic kidney derived HEK293 cell line, in vitro translational model systems. The obtained data indicate that, in both translational assays, the cap analogs synthesized by us when incorporated into mRNA improved its translational properties compared to the ARCA capped transcripts. Furthermore, the introduced modifications enhanced stability of the capped transcripts in HEK293 cells, which become higher compared to that of the transcripts capped with regular cap or with ARCA. Additionally one of the synthesized cap analogs revealed strong translation inhibition potency in RRL system, with IC50 value 1.7 µM.